## Clinical Presentation Analysis **Key Point:** The patient presents with **macrocytic anemia** (MCV 108 fL) with normal B12/methylmalonic acid but **low serum folate (2.8 ng/mL)**, combined with glossitis and angular cheilitis. The vegetarian diet with minimal legumes and concurrent phenytoin use are classic risk factors for folate deficiency. ## Folate Metabolism and Function Folate (as tetrahydrofolate, THF) serves as a **one-carbon donor** in two critical pathways: 1. **Thymidylate synthase pathway** (PRIMARY cause of anemia): - THF (as 5,10-methylene-THF) donates a methyl group to convert **dUMP → dTMP** (deoxythymidine monophosphate) - dTMP is the sole de novo source of thymidine for DNA synthesis - Deficiency → impaired DNA replication in rapidly dividing cells (erythroid precursors, myeloid precursors, GI epithelium) - Result: **Megaloblastic anemia** — nuclear maturation lags behind cytoplasmic development → macrocytic RBCs 2. **Methionine synthase pathway** (secondary): - 5-methylTHF donates its methyl group to convert homocysteine → methionine (requires B12 as cofactor) - Methionine → SAM (S-adenosylmethionine), the universal methyl donor - Deficiency → elevated homocysteine and impaired methylation reactions **High-Yield:** The question asks for the **primary mechanism of anemia**. The macrocytic/megaloblastic anemia in folate deficiency is caused by **impaired DNA synthesis** via the thymidylate synthase pathway — not by methylation defects. Methylation defects (Option A) cause elevated homocysteine and neuropsychiatric symptoms, not megaloblastic anemia. *(Harper's Biochemistry, 31st ed.; Robbins Basic Pathology, 10th ed.)* ## Why Phenytoin Worsens Folate Deficiency | Mechanism | Effect | |-----------|--------| | **Enzyme induction (CYP450)** | Accelerates folate catabolism — PRIMARY mechanism | | **Inhibits intestinal folate conjugase** | Reduces absorption of dietary polyglutamate folate in jejunum | | **Possible weak DHFR inhibition** | Minor contribution; NOT the primary mechanism | **Clinical Pearl:** Phenytoin's **primary** mechanism of folate depletion is **enzyme induction** (CYP450 upregulation → increased folate catabolism), NOT direct dihydrofolate reductase (DHFR) inhibition. DHFR inhibition is the mechanism of **methotrexate** and **trimethoprim**. The explanation table in the original question conflated these mechanisms — phenytoin does not meaningfully inhibit DHFR at therapeutic doses. *(KD Tripathi, Essentials of Medical Pharmacology, 8th ed.)* ## Distinguishing B12 vs. Folate Deficiency | Feature | B12 Deficiency | Folate Deficiency | |---------|---|---| | **Serum B12** | Low | Normal ✓ | | **Serum folate** | Normal or high | Low ✓ (2.8 ng/mL) | | **Methylmalonic acid** | Elevated | Normal ✓ | | **Homocysteine** | Elevated | Elevated | | **Neurological signs** | Yes (subacute combined degeneration) | No | | **MCV** | Macrocytic | Macrocytic ✓ (108 fL) | ## Why the Other Options Are Incorrect - **Option A** (Impaired methylation via reduced 5-MTHF): Methylation impairment does occur in folate deficiency but causes elevated homocysteine and neuropsychiatric effects — NOT the primary cause of megaloblastic anemia. - **Option B** (Decreased absorption in terminal ileum): Folate is absorbed in the **jejunum**, not the terminal ileum (B12 is absorbed in the terminal ileum). This option is anatomically incorrect. - **Option C** (DHFR inhibition by anticonvulsant): DHFR inhibition is the mechanism of methotrexate/trimethoprim, not phenytoin. Phenytoin primarily depletes folate via enzyme induction and reduced intestinal absorption. **Mnemonic: "FOLATE ANEMIA — DNA FIRST"** - **D**NA synthesis impaired (thymidylate synthase → dUMP → dTMP) - **N**uclei cannot mature → megaloblasts - **A**nemia results from ineffective erythropoiesis
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.